• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4619600)   Today's Articles (56)   Subscriber (49403)
For: Kékesi L, Sipos A, Németh G, Pató J, Breza N, Baska F, Őrfi L, Kéri G. Synthesis and biological evaluation of novel pyrido[2,3-b]pyrazines inhibiting both erlotinib-sensitive and erlotinib-resistant cell lines. Bioorg Med Chem Lett 2013;23:6152-5. [DOI: 10.1016/j.bmcl.2013.09.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2013] [Revised: 09/01/2013] [Accepted: 09/03/2013] [Indexed: 02/06/2023]
Number Cited by Other Article(s)
1
Rashid M, Khalid M, Ashraf A, Saleem T, Shafiq I, Shakil MA, Zainab B, El-Kott AF, Yaqub M, Shafiq Z. Multicomponent synthesis of pyrido[2,3-b]pyrazine derivatives: electrochemical DNA sensing, nonlinear optical properties and biological activity. RSC Adv 2023;13:32160-32174. [PMID: 37920758 PMCID: PMC10619479 DOI: 10.1039/d3ra05365b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2023] [Accepted: 10/19/2023] [Indexed: 11/04/2023]  Open
2
Hou W, Dai W, Huang H, Liu SL, Liu J, Huang LJ, Huang XH, Zeng JL, Gan ZW, Zhang ZY, Lan JX. Pharmacological activity and mechanism of pyrazines. Eur J Med Chem 2023;258:115544. [PMID: 37300915 DOI: 10.1016/j.ejmech.2023.115544] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2023] [Revised: 05/25/2023] [Accepted: 06/03/2023] [Indexed: 06/12/2023]
3
Niaz L, Saddique FA, Aslam S, Ahmad M, Mohsin NUA. Recent synthetic methodologies for pyridopyrazines: An update. SYNTHETIC COMMUN 2020. [DOI: 10.1080/00397911.2020.1786123] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
4
Liu JC, Narva S, Zhou K, Zhang W. A Review on the Antitumor Activity of Various Nitrogenous-based Heterocyclic Compounds as NSCLC Inhibitors. Mini Rev Med Chem 2019;19:1517-1530. [DOI: 10.2174/1389557519666190312152358] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2018] [Revised: 02/28/2019] [Accepted: 03/06/2019] [Indexed: 11/22/2022]
5
Hameed A, Zehra ST, Shah SJA, Khan KM, Alharthy RD, Furtmann N, Bajorath J, Tahir MN, Iqbal J. Syntheses, Cholinesterases Inhibition, and Molecular Docking Studies of Pyrido[2,3-b ]pyrazine Derivatives. Chem Biol Drug Des 2015;86:1115-20. [DOI: 10.1111/cbdd.12579] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2015] [Revised: 04/17/2015] [Accepted: 04/27/2015] [Indexed: 12/21/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA